Related Experiment Video
Updated: Jul 14, 2026
09:11
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
Interferon-based treatment of chronic hepatitis C
Claude Souvignet1, Olivier Lejeune, Christian Trepo
1Hospices Civils de Lyon, Hôtel Dieu, Service d'Hépatologie et Gastroentérologie, 69002 Lyon, France.
Biochimie
|June 16, 2007
Summary
Interferon alpha 2 combined with ribavirin significantly improved chronic hepatitis C treatment, achieving a 50% sustained viral response. Pegylated interferon further enhanced efficacy and tolerability, establishing the current standard of care.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Chronic hepatitis C treatment has evolved significantly over the past decade.
- Interferon alpha 2 was initially used as monotherapy with limited long-term success.
- Hepatitis C virus (HCV) infection poses a major global health challenge.
Purpose of the Study:
- To review the evolution of hepatitis C virus treatment strategies.
- To highlight the advancements in antiviral therapies for chronic hepatitis C.
- To discuss the efficacy and mechanisms of interferon-based treatments.
Main Methods:
- Review of interferon alpha 2 monotherapy.
- Analysis of combination therapy with interferon alpha and ribavirin.
- Evaluation of pegylated interferon and ribavirin combination therapy.
Main Results:
- Interferon alpha and ribavirin combination therapy improved sustained viral response to 50%.
- Pegylated interferon with ribavirin achieved nearly 60% sustained virologic response.
- The synergistic effect of interferon and ribavirin remains largely unexplained.
Conclusions:
- Combination therapy with interferon and ribavirin represents a significant advancement in HCV treatment.
- Pegylated interferon offers improved pharmacokinetics and tolerability, becoming the standard of care.
- Ongoing research into novel interferon formulations shows promising preliminary results for future HCV therapies.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...